NEUPHORIA THERAPEUTICS INC (NEUP) Stock Cash Flow
NASDAQ:NEUP - US64136E1029 - Common Stock
13.99 USD
+0.07 (+0.5%)
13.9615 USD
-0.03 (-0.2%)
| TTM (2025-3-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Depreciation Amortization | N/A | 663.20K | N/A | N/A | N/A | |||
| Change In Working Capital | 8.70M | 4.58M | -13.60M | -7.54M | 7.48M | |||
| Interest Paid | N/A | 0.00 | 27.60K | -726.40K | -1.34M | |||
| Taxes Paid | N/A | 0.00 | N/A | N/A | N/A | |||
| Other non cash items | N/A | 1.50M | N/A | N/A | N/A | |||
| OPERATING CASH FLOW | -1.74M | -14.64M | -13.60M | -7.54M | -3.90M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -1.00K | -1.50K | -7.70K | |||
| Other Investing Activity | N/A | 479.50K | 389.50K | -78.70K | -187.40K | |||
| INVESTING CASH FLOW | N/A | 479.50K | 388.60K | -80.20K | -195.10K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -160.00K | -108.90K | -11.87M | -8.29M | |||
| Stock Issued/Repurchased | 8.83M | 3.86M | 20.56M | 43.84M | 3.26M | |||
| Other Financing Activity | N/A | -1.70M | -3.58M | -415.50K | -329.90K | |||
| FINANCING CASH FLOW | 8.75M | 3.86M | 16.87M | 31.55M | -5.36M | |||
| Exchange Rate Effect | 262.30K | -243.80K | -497.80K | -13.10K | 47.60K | |||
| CHANGE IN CASH | 7.13M | -10.54M | 3.17M | 23.92M | -9.41M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -1.74M | -14.64M | -13.60M | -7.54M | -3.90M | |||
| Capital Expenditure | N/A | 0.00 | -1.00K | -1.50K | -7.70K | |||
| FREE CASH FLOW | -1.74M | -14.64M | -13.60M | -7.54M | -3.91M | |||
All data in USD